Drug Profile
Research programme: small molecule therapeutics - Achaogen/Schering-Plough
Latest Information Update: 20 Aug 2009
Price :
$50
*
At a glance
- Originator Achaogen; Schering-Plough
- Class Small molecules
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Unspecified
Most Recent Events
- 22 Feb 2005 NeoGenesis has been acquired and merged into Schering-Plough
- 31 Aug 2004 Preclinical trials in Undefined in USA (unspecified route)